搜索临床试验以:Muscle Invasive Bladder Cancer (MIBC)
总计102165个结果
-
National Cancer Institute (NCI)Rutgers Cancer Institute of New Jersey完全的
-
Memorial Sloan Kettering Cancer CenterNew York University; University of North Carolina, Chapel Hill完全的
-
Tianjin Medical University Second HospitalCSPC Pharmaceutical Group Limited未知
-
Samyang Biopharmaceuticals Corporation终止
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene Corporation完全的
-
Fox Chase Cancer Center终止
-
University of Kansas Medical CenterNational Institutes of Health (NIH)完全的
-
Biofabri, S.LFundación para la Investigación en Urología (FIU)未知
-
Peking University撤销Invasive Bladder Cancer Stage IV中国
-
University of Kansas Medical CenterUniversity of Kansas完全的
-
European Association of Urology Research FoundationGlaxoSmithKline终止膀胱肿瘤法国, 西班牙, 荷兰, 德国, 波兰, 罗马尼亚, 捷克语, 意大利, 俄罗斯联邦, 乌克兰
-
Theralase Inc.University Health Network, Toronto; WCCT Global; Medelis Inc.完全的
-
Seoul National University Hospital未知
-
Mansoura University未知疼痛,术后 | 膀胱癌 | 灵活的膀胱镜检查 | 非肌肉浸润性膀胱癌 (NMIBC)埃及
-
University of Southern CaliforniaNational Cancer Institute (NCI)撤销移行细胞癌 | 浸润性膀胱尿路上皮癌 | II期膀胱尿路上皮癌
-
Spectrum Pharmaceuticals, IncAllergan终止
-
Mayo ClinicNational Cancer Institute (NCI)撤销
-
Endo Pharmaceuticals终止
-
Bioniche Life Sciences Inc.终止原位癌 | 局部肿瘤复发 | 膀胱肿瘤 | 分枝杆菌 | 移行细胞癌美国, 加拿大, 波兰, 德国, 荷兰, 英国
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); OSI Pharmaceuticals完全的
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Ministry of Health, France; National Cancer Institute, France 和其他合作者未知